Moneycontrol

You are Here : API facility to boost revenue by 5-10%: Nectar Lifesciences

Friday, 02:29

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the companys revenues by 5-10%.
MAR 25, 2017
01:21 PM

cnbc tv18 shows

Search
All Shows
Go

NOW PLAYING

Overdrive

Overdrive brings to you a brand of automotive experience: a borderless, seamless world, which is the one pit stop shop for anything and everything on wheels. Spanning online, print, on ground and television, CNBC-TV18's Overdrive caters to the need of everyone  - from the first time auto bu ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On